E. Giesbrecht

446 total citations
19 papers, 326 citations indexed

About

E. Giesbrecht is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, E. Giesbrecht has authored 19 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pediatrics, Perinatology and Child Health and 3 papers in Oncology. Recurrent topics in E. Giesbrecht's work include Neonatal Health and Biochemistry (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Ion Transport and Channel Regulation (2 papers). E. Giesbrecht is often cited by papers focused on Neonatal Health and Biochemistry (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Ion Transport and Channel Regulation (2 papers). E. Giesbrecht collaborates with scholars based in Canada, United States and United Kingdom. E. Giesbrecht's co-authors include Gideon Koren, S J Soldin, Mark Greenberg, Joseph Kapelushnik, Julia Klein, Z. Verjee, Jake J. Thiessen, Brenda L. Gallie, Andrew Budning and Joan M. O’Brien and has published in prestigious journals such as New England Journal of Medicine, Journal of Pharmacology and Experimental Therapeutics and Clinical Chemistry.

In The Last Decade

E. Giesbrecht

18 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Giesbrecht Canada 9 104 99 85 71 66 19 326
François Chast France 8 31 0.3× 73 0.7× 28 0.3× 129 1.8× 43 0.7× 35 381
Jean Luc André France 7 34 0.3× 150 1.5× 41 0.5× 5 0.1× 40 0.6× 8 325
Tanvi Shah United States 8 48 0.5× 48 0.5× 21 0.2× 12 0.2× 37 0.6× 25 332
R. J. Hené Netherlands 6 40 0.4× 30 0.3× 23 0.3× 7 0.1× 18 0.3× 12 322
Nicolas Muruve United States 10 125 1.2× 46 0.5× 34 0.4× 3 0.0× 44 0.7× 21 429
Kyo M Japan 7 44 0.4× 42 0.4× 27 0.3× 3 0.0× 56 0.8× 26 339
Rajan Kapoor India 11 39 0.4× 37 0.4× 44 0.5× 3 0.0× 45 0.7× 76 360
Sumiko Kohashi Japan 9 19 0.2× 59 0.6× 53 0.6× 4 0.1× 20 0.3× 29 252
S. Flechner United States 7 48 0.5× 51 0.5× 44 0.5× 2 0.0× 21 0.3× 16 393
Yuko Kanbayashi Japan 11 17 0.2× 22 0.2× 176 2.1× 6 0.1× 27 0.4× 46 356

Countries citing papers authored by E. Giesbrecht

Since Specialization
Citations

This map shows the geographic impact of E. Giesbrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Giesbrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Giesbrecht more than expected).

Fields of papers citing papers by E. Giesbrecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Giesbrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Giesbrecht. The network helps show where E. Giesbrecht may publish in the future.

Co-authorship network of co-authors of E. Giesbrecht

This figure shows the co-authorship network connecting the top 25 collaborators of E. Giesbrecht. A scholar is included among the top collaborators of E. Giesbrecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Giesbrecht. E. Giesbrecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Giesbrecht, E. & Z. Verjee. (1999). DETECTION OF GAMMA-HYDROXY BUTYRATE IN URINE AND SERUM BY GC-FID. Therapeutic Drug Monitoring. 21(4). 470–470. 2 indexed citations
2.
Verjee, Z. & E. Giesbrecht. (1999). COMPARISION OF IMMUNOASSAY DETECTION FOR DRUGS OF ABUSE WITH AUTOMATED HPLC SYSTEM. Therapeutic Drug Monitoring. 21(4). 470–470. 2 indexed citations
3.
Ito, Shinya, Robert M. Gow, Zul Verjee, et al.. (1998). Intravenous and Oral Propafenone for Treatment of Tachycardia in Infants and Children: Pharmacokinetics and Clinical Response. The Journal of Clinical Pharmacology. 38(6). 496–501. 19 indexed citations
4.
Furuya, Katryn N., P. Durie, E A Roberts, et al.. (1997). MEASUREMENT OF PARA-AMINOHIPPURIC ACID (PAHA) AS A NEW PROGNOSTIC TEST IN FULMINANT HEPATIC FAILURE. Journal of Pediatric Gastroenterology and Nutrition. 25(4). 442–442. 2 indexed citations
5.
Chan, Helen S. L., George Deboer, Jake J. Thiessen, et al.. (1996). Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation.. PubMed. 2(9). 1499–508. 101 indexed citations
6.
Johnson, Daniel M., et al.. (1996). Measurement of serum acetylsalicylic acid in a porcine model of aspirin overdose.. PubMed. 38(6). 409–12. 2 indexed citations
7.
Verjee, Z., Katryn N. Furuya, E A Roberts, et al.. (1994). Glycine conjugation of para-aminobenzoic acid (PABA) as a quantitative test for liver function. Clinical Biochemistry. 27(3). 228–229. 1 indexed citations
8.
Deboer, George, J E Kingston, Gideon Koren, et al.. (1994). Cyclosporin-modulated chemotherapy with focal cryo/laser therapy. Anti-Cancer Drugs. 5. 57–57. 1 indexed citations
9.
Verjee, Z. & E. Giesbrecht. (1994). Lidocaine and HPLC assay for anticonvulsants. Clinical Chemistry. 40(5). 833–833. 1 indexed citations
10.
Koren, Gideon, Earl D. Silverman, Robert P. Sundel, et al.. (1991). Decreased protein binding of salicylates in Kawasaki disease. The Journal of Pediatrics. 118(3). 456–459. 22 indexed citations
11.
Robieux, I., et al.. (1991). Diurnal variation of methotrexate disposition in children with acute leukaemia. European Journal of Clinical Pharmacology. 41(5). 425–427. 13 indexed citations
12.
Koren, Gideon, Joseph Kapelushnik, Julia Klein, et al.. (1990). Systemic Exposure to Mercaptopurine as a Prognostic Factor in Acute Lymphocytic Leukemia in Children. New England Journal of Medicine. 323(1). 17–21. 111 indexed citations
13.
Louis, Patrick J., Mhairi G. MacDonald, E. Giesbrecht, & S J Soldin. (1989). An Evaluation of the Kodak Ektachem Clinical Chemistry Slide for Theophylline. Therapeutic Drug Monitoring. 11(1). 93–96. 2 indexed citations
14.
Koren, Gideon, et al.. (1989). The effects of mannitol diuresis on digoxin and phenobarbital handling by the kidney: implications for tubular reabsorption and secretion of the cardiac glycoside.. PubMed. 12(5). 279–84. 2 indexed citations
15.
Koren, Gideon, E. Giesbrecht, S J Soldin, et al.. (1988). Effects of quinidine on the renal tubular and biliary transport of digoxin: in vivo and in vitro studies in the dog.. Journal of Pharmacology and Experimental Therapeutics. 247(3). 1193–1198. 11 indexed citations
16.
Giesbrecht, E., et al.. (1987). Receptor Radioligand System for Measuring Digoxin Activity. Therapeutic Drug Monitoring. 9(1). 61–66. 8 indexed citations
17.
Soldin, S J, et al.. (1986). Further problems with digoxin measurement.. PubMed. 32(8). 1591–1591. 9 indexed citations
18.
Giesbrecht, E., et al.. (1986). A study of lipid effects on the digoxin immunoassay and on the binding to and activity of Na+/K+-ATPase. Clinical Biochemistry. 19(4). 195–200. 14 indexed citations
19.
Giesbrecht, E.. (1972). Infectious mononucleosis--the kissing disease.. PubMed. 68(2). 37–40. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026